Stock CARM CARISMA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Carisma Therapeutics, Inc.

Equities

CARM

US14216R1014

Market Closed - Nasdaq
Other stock markets
 21:00:00 10/05/2024 BST 		5-day change 1st Jan Change
1.48 USD -1.99% Intraday chart for Carisma Therapeutics, Inc. -8.64% -49.49%
05-09 Carisma Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-02 Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
AQ
Carisma Therapeutics : Corporate Presentation May 2024
PU
Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference
PR
Carisma Therapeutics : Corporate Presentation May 2024
PU
Carisma Therapeutics : Corporate Presentation May 2024
PU
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
PR
Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy Annual Meeting
AQ
Carisma Therapeutics to Present at Upcoming Conferences
PR
Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
AQ
Carisma Therapeutics Announces Changes to its Board of Directors
PR
Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference
PR
Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PR
Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte
PR
Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference
PR
Carisma Presents Pre-Clinical Proof of Concept for in vivo CAR-M using mRNA platform in collaboration with Moderna at SITC
AQ
Carisma to Present First Results From in vivo CAR-M Collaboration with Moderna at SITC 2023
AQ
Carisma Therapeutics to Present at Upcoming Investor Conferences
PR
Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR Summit
AQ
Carisma Therapeutics : Corporate Presentation
PU
Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR Summit
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CARM Stock
  4. News Carisma Therapeutics, Inc.
  5. Press Releases